Dual Receptor Agonist Metabolic Peptide (TRZ)

Dual Receptor Agonist Metabolic Peptide (TRZ)

0 customer reviews Sold: 0

€200.00

Weight loss and Insulin Sensitivity

TIRZ is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. It is currently being researched for its powerful effects on weight loss, appetite regulation, and metabolic correction. It works by mimicking two incretin hormones, which play key roles in insulin secretion, glucose metabolism, and satiety.

38 in stock

Add to cart

Buy Now

Categories: Bio-Identical Research Peptides Rejuvatide-peptides

Description
Reviews (0)

Key Benefits / Research Highlights

Promotes weight loss by reducing appetite and improving satiety
Improves insulin sensitivity and blood sugar regulation
Reduces food cravings and binge tendencies
May lower blood pressure, inflammation markers, and cholesterol
Promotes fat loss while preserving lean muscle mass
May support liver health and reduce fatty liver markers

Link to studies

https://pubmed.ncbi.nlm.nih.gov/?term=Tirzepatide

Reviews

There are no reviews yet.

Be the first to review “Dual Receptor Agonist Metabolic Peptide (TRZ)”

Top